Skip to content

Arrowhead Research ARWR Other operating expenses

Other operating expenses at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-1.1%
Tenet Healthcare logo
Tenet HealthcareTHC
$1.12B+2.9%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$200K
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's other operating expenses?
Arrowhead Research (ARWR) reported other operating expenses of $215M in Q1 2026.
How has Arrowhead Research's other operating expenses changed year-over-year?
Arrowhead Research's other operating expenses increased by 33.1% year-over-year, from $161.51M to $215M.
What is the long-term trend for Arrowhead Research's other operating expenses?
Over 4 years (2021 to 2025), Arrowhead Research's other operating expenses has grown at a 26.3% compound annual growth rate (CAGR), from $287.33M to $731.1M.